Evaluating Newly Approved Drugs for Multidrug-resistant TB
Condition: Tuberculosis, Multidrug-ResistantInterventions: Drug: Bedaquiline; Drug: Delamanid; Drug: Clofazimine; Drug: Levofloxacin; Drug: Moxifloxacin; Drug: Linezolid; Drug: PyrazinamideSponsors: Médecins Sans Frontières France; Partners in Health; Harvard Medical School; Epicentre; Institute of Tropical Medicine, Belgium; Ministry of Health, Kyrgyzstan; National Center for Tuberculosis Problems, Kazakhstan; Ministry of Health, Lesotho; National Center for Tuberculosis and Lung Diseases, Georgia; Socios En Salud, PeruNot yet recruitin...
Source: ClinicalTrials.gov - April 25, 2016 Category: Research Source Type: clinical trials
Same-day ART Initiation Versus Standard of Care After Positive HIV-test Result in Rural Lesotho
Condition: HIV InfectionInterventions: Other: Same-day ART initiation; Other: Standard of careSponsors: Swiss Tropical & Public Health Institute; SolidarMed - Swiss Organization for Health in Africa; Research Coordination Unit, Ministry of Health of Lesotho; District Health Management Team of Butha-Buthe, Lesotho; University of Basel; University of Geneva, SwitzerlandNot yet recruiting - verified February 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2016 Category: Research Source Type: clinical trials
Same-day ART Initiation Versus Standard of Care After Positive HIV-test Result in Rural Lesotho
Condition: HIV InfectionInterventions: Other: Same-day ART initiation; Other: Standard of careSponsors: Swiss Tropical & Public Health Institute; SolidarMed - Swiss Organization for Health in Africa; Research Coordination Unit, Ministry of Health of Lesotho; District Health Management Team of Butha-Buthe, Lesotho; University of Basel; University of Geneva, SwitzerlandRecruiting - verified February 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2016 Category: Research Source Type: clinical trials
